2H-1-benzopyran-2-carboxaldehyd | 49836-48-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并吡喃
• 英文名称: 2H-1-benzopyran-2-carboxaldehyd
• 英文别名: 1-benzopyran-2-carboxaldehyde；benzopyran-2-carbaldehyde；2H-chromenecarbaldehyde；chromene-2-carbaldehyde；chromene-carbaldehyde；Chromenecarbaldehyde；2H-chromene-2-carbaldehyde
• CAS: 49836-48-8
• 化学式: C₁₀H₈O₂
• 分子量: 160.172
• InChiKey: DJPNFFJPIXWYAZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• Non-steroidal farnesoid x receptor modulators and methods for the use thereof
  申请人：Downes R Michael

  公开号：US20060128764A1

  公开（公告）日：2006-06-15

  The efficient regulation of cholesterol synthesis, metabolism, acquisition, and transport is an essential component of lipid homeostasis. The farnesoid X receptor (FXR) is a transcriptional sensor for bile acids, the primary product of cholesterol metabolism. Accordingly, the development of potent, selective, small molecule agonists, partial agonists, and antagonists of FXR would be an important step in further deconvoluting FXR physiology. In accordance with the present invention, the identification of novel potent FXR activators is described. Two derivatives of invention compounds, bearing stilbene or biaryl moieties, contain members that are the most potent FXR agonists reported to date in cell-based assays. These compounds are useful as chemical tools to further define the physiological role of FXR as well as therapeutic leads for the treatment of diseases linked to cholesterol, bile acids and their metabolism and homeostasis.

  胆固醇合成、代谢、获取和运输的高效调节是脂类稳态的重要组成部分。法尼索德X受体（FXR）是胆固醇代谢的主要产物——胆汁酸的转录传感器。因此，开发有效、选择性、小分子的FXR激动剂、部分激动剂和拮抗剂将是进一步解析FXR生理学的重要一步。根据本发明，描述了新型有效的FXR激动剂的鉴定。发明化合物的两个衍生物，携带了联苯或联苯醚基团，包含了迄今为止在细胞基础实验中报道的最有效的FXR激动剂。这些化合物可用作化学工具，进一步定义FXR的生理作用，以及治疗与胆固醇、胆汁酸及其代谢和稳态相关的疾病的治疗前导化合物。
• Non-steroidal farnesoid x receptor modulators
  申请人：Downes R. Michael

  公开号：US20060223879A1

  公开（公告）日：2006-10-05

  The efficient regulation of cholesterol synthesis, metabolism, acquisition, and transport is an essential component of lipid homeostasis. The farnesoid X receptor (FXR) is a transcriptional sensor for bile acids, the primary product of cholesterol metabolism. Accordingly, the development of potent, selective, small molecule agonists, partial agonists, and antagonists of FXR would be an important step in further deconvoluting FXR physiology. In accordance with the present invention, the identification of novel potent FXR activators is described. Two derivatives of invention compounds, bearing stilbene or biaryl moieties, contain members that are the most potent FXR agonists reported to date in cell-based assays. These compounds are useful as chemical tools to further define the physiological role of FXR as well as therapeutic leads for the treatment of diseases linked to cholesterol, bile acids and their metabolism and homeostasis.

  胆固醇的合成、代谢、获取和转运的高效调节是脂质稳态的重要组成部分。法尼索德X受体（FXR）是胆汁酸的转录感受器，是胆固醇代谢的主要产物。因此，开发有效、选择性、小分子激动剂、部分激动剂和拮抗剂对于进一步解析FXR生理学是重要的一步。根据本发明，描述了新型有效的FXR激动剂的鉴定。两种发明化合物的衍生物，含有联苯乙烯或联芳基团，包含目前在细胞基础实验中报道的最有效的FXR激动剂成员。这些化合物可用作化学工具，进一步定义FXR的生理作用，以及治疗与胆固醇、胆汁酸及其代谢和稳态相关的疾病的治疗前导化合物。
• BIFUNCTIONAL AGENTS POSSESSING ANTIOXIDANT AND ANTIARRHYTHMIC ACTIVITY
  申请人：Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.

  公开号：EP1301504A1

  公开（公告）日：2003-04-16
• US7671085B2
  申请人：——

  公开号：US7671085B2

  公开（公告）日：2010-03-02
• [EN] BIFUNCTIONAL AGENTS POSSESSING ANTIOXIDANT AND ANTIARRHYTHMIC ACTIVITY<br/>[FR] AGENTS BIFONCTIONNELS A ACTIVITE ANTIOXYDANTE ET ANTIARYTHMIQUE
  申请人：UNI PHARMA KLEON TSETIS PHARMACEUTICAL LAB SA

  公开号：WO2002004438A1

  公开（公告）日：2002-01-17

  The present invention relates to novel bifunctional agents possessing antioxidant and antiarrhytmic activity, methods for the synthesis of the same and their applications in treating ischemia-reperfusion injury, as well as a variety of disorders related to free radicals and/or arrhythmias. These bifunctional drugs should preferentially segregate in the membrane and produce their antiarrhytmic effects while, at the same time, help in protecting the membrane lipids by scavenging free radicals. The present invention comprises compounds represented by Formula (I), wherein R1, R2, R3, R4, R5 are further defined.